ProShare Advisors’s Rockwell Medical RMTI Stock Holding History

ProShare Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-169	Closed	-$22K	–	2396
2021 Q1	$22K	Buy	169 +29	+21%	+$4.29K	﹤0.01%	2256
2020 Q4	$16K	Buy	+140	New	+$15.7K	﹤0.01%	2090
2014 Q4	–	Sell	-146	Closed	-$147K	–	2092
2014 Q3	$147K	Sell	146 -33	-18%	-$37.3K	﹤0.01%	2082
2014 Q2	$236K	Sell	179 -182	-50%	-$219K	﹤0.01%	2072
2014 Q1	$503K	Buy	+361	New	+$469K	0.01%	1865
2013 Q4	–	Sell	-226	Closed	-$284K	–	1760
2013 Q3	$284K	Sell	226 -6	-3%	-$4.07K	0.01%	1932
2013 Q2	$92K	Buy	+232	New	+$98.4K	﹤0.01%	2277

Other funds holding RMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

ProShare Advisors's RMTI Position: Q2 2021 in Review

ProShare Advisors sold out of Rockwell Medical (RMTI) in Q2 2021, closing a stake of 169 shares — an estimated $22K sold.

ProShare Advisors first reported a position in RMTI in Q2 2013 and held it in 7 quarters. The position peaked at $503K in Q1 2014. 78 funds tracked by Wall St. Rank hold RMTI as of Q2 2021.

ProShare Advisors reported no remaining Rockwell Medical position as of Q2 2021 after selling out during the quarter.
ProShare Advisors sold 169 Rockwell Medical shares in Q2 2021, an estimated $22K.
ProShare Advisors first reported a position in Rockwell Medical in Q2 2013 and held it in 7 quarters.
ProShare Advisors's Rockwell Medical position peaked at $503K in Q1 2014.
78 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2021.

Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.